These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21854920)

  • 21. The cost of clinical mastitis in the first 30 days of lactation: An economic modeling tool.
    Rollin E; Dhuyvetter KC; Overton MW
    Prev Vet Med; 2015 Dec; 122(3):257-64. PubMed ID: 26596651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution and antimicrobial resistance of clinical and subclinical mastitis pathogens in dairy cows in Rhône-Alpes, France.
    Botrel MA; Haenni M; Morignat E; Sulpice P; Madec JY; Calavas D
    Foodborne Pathog Dis; 2010 May; 7(5):479-87. PubMed ID: 19919286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lifetime risk and cost of clinical mastitis in dairy cows in relation to heifer rearing conditions in southwest Sweden.
    Hultgren J; Svensson C
    J Dairy Sci; 2009 Jul; 92(7):3274-80. PubMed ID: 19528604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Addition of meloxicam to the treatment of bovine clinical mastitis results in a net economic benefit to the dairy farmer.
    van Soest FJS; Abbeloos E; McDougall S; Hogeveen H
    J Dairy Sci; 2018 Apr; 101(4):3387-3397. PubMed ID: 29398019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Costs of clinical mastitis and mastitis prevention in dairy herds.
    Miller GY; Bartlett PC; Lance SE; Anderson J; Heider LE
    J Am Vet Med Assoc; 1993 Apr; 202(8):1230-6. PubMed ID: 8496076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production effects related to mastitis and mastitis economics in dairy cattle herds.
    Seegers H; Fourichon C; Beaudeau F
    Vet Res; 2003; 34(5):475-91. PubMed ID: 14556691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stochastic modeling to determine the economic effects of blanket, selective, and no dry cow therapy.
    Huijps K; Hogeveen H
    J Dairy Sci; 2007 Mar; 90(3):1225-34. PubMed ID: 17297099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of prepartum dry cow antibiotic treatment in dairy heifers on udder health and milk production.
    Sampimon OC; De Vliegher S; Barkema HW; Sol J; Lam TJ
    J Dairy Sci; 2009 Sep; 92(9):4395-403. PubMed ID: 19700699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors associated with short-term post-treatment outcomes of clinical mastitis.
    Pinzón-Sánchez C; Ruegg PL
    J Dairy Sci; 2011 Jul; 94(7):3397-410. PubMed ID: 21700025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Costs of mastitis: facts and perception.
    Huijps K; Lam TJ; Hogeveen H
    J Dairy Res; 2008 Feb; 75(1):113-20. PubMed ID: 18226298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of pathogen-specific clinical mastitis on milk yield in dairy cows.
    Gröhn YT; Wilson DJ; González RN; Hertl JA; Schulte H; Bennett G; Schukken YH
    J Dairy Sci; 2004 Oct; 87(10):3358-74. PubMed ID: 15377615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gram-typing of mastitis bacteria in milk samples using flow cytometry.
    Langerhuus SN; Ingvartsen KL; Bennedsgaard TW; Røntved CM
    J Dairy Sci; 2013 Jan; 96(1):267-77. PubMed ID: 23141826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The selective treatment of clinical mastitis based on on-farm culture results: I. Effects on antibiotic use, milk withholding time, and short-term clinical and bacteriological outcomes.
    Lago A; Godden SM; Bey R; Ruegg PL; Leslie K
    J Dairy Sci; 2011 Sep; 94(9):4441-56. PubMed ID: 21854917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Providing probability distributions for the causal pathogen of clinical mastitis using naive Bayesian networks.
    Steeneveld W; van der Gaag LC; Barkema HW; Hogeveen H
    J Dairy Sci; 2009 Jun; 92(6):2598-609. PubMed ID: 19447992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationships between milk culture results and composite milk somatic cell counts in Norwegian dairy cattle.
    Reksen O; Sølverød L; Østerås O
    J Dairy Sci; 2008 Aug; 91(8):3102-13. PubMed ID: 18650286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The value of pathogen information in treating clinical mastitis.
    Cha E; Smith RL; Kristensen AR; Hertl JA; Schukken YH; Tauer LW; Welcome FL; Gröhn YT
    J Dairy Res; 2016 Nov; 83(4):456-463. PubMed ID: 27845019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Failure and preventive costs of mastitis on Dutch dairy farms.
    van Soest FJS; Santman-Berends IMGA; Lam TJGM; Hogeveen H
    J Dairy Sci; 2016 Oct; 99(10):8365-8374. PubMed ID: 27474980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioeconomic modeling of lactational antimicrobial treatment of new bovine subclinical intramammary infections caused by contagious pathogens.
    van den Borne BH; Halasa T; van Schaik G; Hogeveen H; Nielen M
    J Dairy Sci; 2010 Sep; 93(9):4034-44. PubMed ID: 20723677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severity of E. coli mastitis is mainly determined by cow factors.
    Burvenich C; Van Merris V; Mehrzad J; Diez-Fraile A; Duchateau L
    Vet Res; 2003; 34(5):521-64. PubMed ID: 14556694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determining the optimum replacement policy for Holstein dairy herds in Iran.
    Kalantari AS; Mehrabani-Yeganeh H; Moradi M; Sanders AH; De Vries A
    J Dairy Sci; 2010 May; 93(5):2262-70. PubMed ID: 20412942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.